| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/18/2007 | WO2006138259A3 Chemokine receptor binding compounds |
| 05/18/2007 | WO2006122020A3 Process for production of 4-biphenylyazetidin-2-ones |
| 05/18/2007 | CA2629258A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | CA2628934A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 05/18/2007 | CA2627358A1 Heterocyclic modulators of atp-binding cassette transporters |
| 05/18/2007 | CA2627114A1 P2x7 receptor antagonists and methods of use |
| 05/17/2007 | US20070112210 Heterogeneous ruthenium catalyst, methods for hydrogenating a carbocyclic aromatic group, and nucleus-hydrogenated diglycidyl ether of bisphenols a and f |
| 05/17/2007 | US20070112192 3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 05/17/2007 | US20070112063 e.g. 4-(3-Chlorophenylaminothiocarbonylamino)-3,4-dihydro-2,2-dimethyl-6-fluoro-2H-1-benzopyran; potassium channel activator; relaxant activity on smooth muscle cells; active on the pancreatic endocrine tissue as inhibitors of insulin secretion |
| 05/17/2007 | US20070112061 Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound |
| 05/17/2007 | US20070112040 Amino nicotinate derivatives as glucokinase (GLK) modulators |
| 05/17/2007 | US20070112031 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070112000 Chemical compounds |
| 05/17/2007 | US20070111991 10,11-Dihydro-dibenzo[b,f]oxepine-10-carboxylic acid [(1S*,2S*,4R*)-4-butylcarbamoyl-2-hydroxy-1-(3-hydroxy-benzyl)-pentyl]-amide; treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation |
| 05/16/2007 | EP1785417A2 Novel non-psychotropic cannabinoids |
| 05/16/2007 | EP1785416A2 9, 10-alpha, alpha-OH-Taxane Analogs and methods for production thereof |
| 05/16/2007 | EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 05/16/2007 | EP1784401A1 Urea derivatives as calcium channel blockers |
| 05/16/2007 | EP1784400A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/16/2007 | EP1784393A1 Quinazolines useful as modulators of ion channels |
| 05/16/2007 | EP1615634B1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 05/16/2007 | EP1465638B1 Phosphate transport inhibitors |
| 05/16/2007 | EP1434485B1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives for use as pesticides |
| 05/16/2007 | EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 05/16/2007 | CN1964970A Iap的抑制剂 Iap inhibitors |
| 05/16/2007 | CN1964965A Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 05/16/2007 | CN1964950A Propane-1,3-dione derivative or its salt |
| 05/16/2007 | CN1964947A Pyrazole derivatives, compositions containing such compounds and methods of use |
| 05/16/2007 | CN1964946A 2-propylene-1-ones as hsp70 inducer |
| 05/16/2007 | CN1964944A Indole derivatives as antiviral agents |
| 05/16/2007 | CN1964718A Leptomycin compounds |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315805C Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217819 Immobilization of taxane; anticancer, antitumor agents |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217712 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors |
| 05/15/2007 | US7217465 For use in light-emitting device; can be easily applied to vacuum vapor deposition and exhibit long wavelength light |
| 05/15/2007 | CA2295087C Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 05/15/2007 | CA2148612C 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as pesticides |
| 05/10/2007 | WO2007053765A2 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053662A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053657A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | WO2007053498A1 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053495A2 Compounds useful as antagonists of ccr2 |
| 05/10/2007 | WO2007053131A2 Acrylamide derivatives as antibiotic agents |
| 05/10/2007 | WO2007053094A1 CHROMAN COMPOUNDS AS 5 -HTlB ANTAGONISTS |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007051920A1 Methanone compounds and the use thereof in pharmaceutical compositions, in particular for treating cardiovascular diseases |
| 05/10/2007 | WO2007051846A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007051845A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007051735A1 Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| 05/10/2007 | WO2007051333A1 Triazine beta-secretase inhibitors |
| 05/10/2007 | WO2007051306A1 New methods for the preparation of taxanes using chiral auxiliaries |
| 05/10/2007 | WO2007025709A3 Organic compounds |
| 05/10/2007 | WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy |
| 05/10/2007 | WO2007007282A3 Azabicyclo derivatives as muscarinic receptor antagonists |
| 05/10/2007 | WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof |
| 05/10/2007 | WO2006016178A8 Enantioselective process |
| 05/10/2007 | WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
| 05/10/2007 | US20070106095 Vitamin d receptor modulators |
| 05/10/2007 | US20070105913 Alkynyl aryl carboxamides |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105893 e.g. 2-[(4-Ethoxyphenyl)methyl]-1-(3-methylbutyl)-N,N-bis(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide; agonists at cannabinoid 2 receptor; analgesic agent, anticarcinogenic agent, neurodegenerative diseases; multiple sclerosis, Parkinson's disease, Huntington's chorea or Alzheimer's disease. |
| 05/10/2007 | US20070105880 Process for the preparation of alfuzosin |
| 05/10/2007 | US20070105871 1,3,4-Substituted pyrazoles as 5-ht receptor antagonists for the treatment of psychoses and neurological disorders |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/10/2007 | US20070105853 2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity |
| 05/10/2007 | US20070105847 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| 05/10/2007 | US20070105839 2, 4-Di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 05/10/2007 | US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide |
| 05/10/2007 | DE19522167B4 1,2-Difluornaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen 1,2-difluoronaphthalene-derivatives and their use in liquid crystal mixtures |
| 05/10/2007 | CA2628486A1 Tricyclo substituted amides |
| 05/10/2007 | CA2628259A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2628173A1 Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627943A1 New methods for the preparation of taxanes using chiral auxiliaries |
| 05/10/2007 | CA2627910A1 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2627813A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 05/10/2007 | CA2626475A1 Tricyclo substituted amides |
| 05/09/2007 | EP1783121A1 Azo compounds and process for production thereof |
| 05/09/2007 | EP1783113A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 05/09/2007 | EP1782811A1 Novel antimalaria agent containing heterocyclic compound |
| 05/09/2007 | EP1781662A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 05/09/2007 | EP1781650A1 Novel compounds having an anti-bacterial activity |
| 05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 05/09/2007 | EP1781639A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 05/09/2007 | EP1781636A1 Pyrrole derivatives, their preparation and their therapeutic use |
| 05/09/2007 | EP1781635A2 Potassium channel inhibitors |
| 05/09/2007 | EP1781633A1 Novel antidiabetic compounds |
| 05/09/2007 | EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors |
| 05/09/2007 | EP1781621A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |